Search alternatives:
small decrease » small increased (Expand Search)
Showing 801 - 820 results of 2,520 for search '(( (dramatic OR aromatic) decrease ) OR ( ((dramatic decrease) OR (small decrease)) ))', query time: 0.44s Refine Results
  1. 801
  2. 802
  3. 803
  4. 804
  5. 805
  6. 806
  7. 807
  8. 808

    Data_Sheet_1_Subthreshold amyloid deposition, cerebral small vessel disease, and functional brain network disruption in delayed cognitive decline after stroke.docx by Jae-Sung Lim (532986)

    Published 2024
    “…We postulated that the functional segregation observed during post-stroke compensation could be disrupted by underlying amyloid pathology or cerebral small vessel disease (cSVD), leading to delayed-onset PSCD.…”
  9. 809

    Table 1_Enhancement of oxaliplatin efficacy and amelioration of intestinal epithelial damage by Lactobacillus rhamnosus GG through modulation of gut microbiota.xlsx by Zijie Zhang (2543533)

    Published 2025
    “…Background<p>Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide, necessitating extensive research into effective treatment strategies. …”
  10. 810
  11. 811
  12. 812

    Data Sheet 1_Ultra-small curcumin-ruthenium coordination polymer nanodots prevent renal ischemia-reperfusion injury and the progression to chronic kidney disease.docx by Xian Liu (191882)

    Published 2025
    “…This study presents the synthesis of curcumin ultra-small coordination polymer (Ru/Cur) nanodots and their application in scavenging ROS in renal tissues. …”
  13. 813

    Table 1_The CD300c antibody CL7 suppresses tumor growth by regulating the tumor microenvironment in non-small cell lung carcinoma.docx by Soyoung Kim (117362)

    Published 2025
    “…<p>Despite advances in therapy, non-small cell lung cancer (NSCLC) continues to rank among the deadliest cancers worldwide. …”
  14. 814

    Data Sheet 2_Prognostic value of lymph node ratio in patients with non-small cell lung cancer: a systematic review and meta-analysis.zip by Junhuang Zheng (21629486)

    Published 2025
    “…This meta-analysis aims to evaluate the prognostic value of LNR in patients with non-small cell lung cancer (NSCLC).</p>Methods<p>A systematic literature search was conducted in PubMed, Embase, Cochrane, and Web of Science databases, with the search date up to January 7, 2025. …”
  15. 815

    Data Sheet 1_Prognostic value of lymph node ratio in patients with non-small cell lung cancer: a systematic review and meta-analysis.zip by Junhuang Zheng (21629486)

    Published 2025
    “…This meta-analysis aims to evaluate the prognostic value of LNR in patients with non-small cell lung cancer (NSCLC).</p>Methods<p>A systematic literature search was conducted in PubMed, Embase, Cochrane, and Web of Science databases, with the search date up to January 7, 2025. …”
  16. 816

    Data Sheet 1_Radiomics reveals the biological basis for non-small cell lung cancer prognostic stratification by reflecting tumor immune microenvironment heterogeneity.docx by Qing Huang (240196)

    Published 2025
    “…Background<p>Current radiomic non-small cell lung cancer prognostic models predominantly depend on statistical correlations, lacking robust biological validation. …”
  17. 817

    Data Sheet 1_Transcriptomic analysis of ROS1+ non-small cell lung cancer reveals an upregulation of nucleotide synthesis and cell adhesion pathways.pdf by Marc Terrones (18094462)

    Published 2024
    “…Introduction<p>The transcriptomic characteristics of ROS1+ non-small cell lung cancer (NSCLC) represent a crucial aspect of its tumor biology. …”
  18. 818

    Image 1_Cerebral small vessel disease as a possibly immune-related adverse event of immunotherapy in lung cancer patients: a retrospective study.tif by Na Wu (240778)

    Published 2025
    “…Background<p>This clinical study aims to investigate the incidence of cerebral small vessel disease (CSVD) in lung cancer patients treated with ICIs and to analyze its risk factors by comparing the clinical features and laboratory tests in ICIs-treated lung cancer patients with or without CSVD.…”
  19. 819

    Presentation 1_Efficacy of disitamab vedotin in non-small cell lung cancer with HER2 alterations: a multicenter, retrospective real-world study.pdf by Meiling Zhang (352540)

    Published 2024
    “…Background<p>Non-small cell lung cancer (NSCLC) with human epidermal growth factor receptor 2 (HER2) alterations poses a substantial treatment challenge. …”
  20. 820